Cargando…

Impact of (68)Ga-DOTATOC PET/CT in comparison to (111)In-Octreotide SPECT/CT in management of neuro-endocrine tumors: A case report

RATIONALE: In the diagnostics of neuroendocrine tumors (NETs), scintigraphy and Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) with (111)Indium-Octreotide occupy a prominent place. The introduction in clinical practice of (68)Gallium-labelled somatostatin analogues (DOTA-T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tolomeo, Anna, Lopopolo, Gaetano, Dimiccoli, Vincenzo, Perioli, Luana, Modoni, Sergio, Scilimati, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035109/ https://www.ncbi.nlm.nih.gov/pubmed/32049844 http://dx.doi.org/10.1097/MD.0000000000019162

Ejemplares similares

Searching for primaries in patients with neuroendocrine tumors (NET) of unknown primary and clinically suspected NET: Evaluation of Ga-68 DOTATOC PET/CT and In-111 DTPA octreotide SPECT/CT
por: Schreiter, Nils Friedemann, et al.
Publicado: (2014)

Osteoblastic bone metastases from neuroendocrine tumor (NET) of unknown origin detected by (18)fluorocholine PET/CT and its comparison with (68)gallium-DOTATOC PET/CT: Case report and review of the literature
por: Bongiovanni, Alberto, et al.
Publicado: (2017)

68Ga-DOTA-D Phe1-Tyr3-Octreotide (DOTATOC)-PET/CT in a Suspected Case of Recurrent Meningioma
por: Jain, Sachin, et al.
Publicado: (2017)

[(68)Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning
por: Gehler, Barbara, et al.
Publicado: (2009)

Intravenous contrast-enhanced CT can be used for CT-based attenuation correction in clinical (111)In-octreotide SPECT/CT
por: Klausen, Thomas Levin, et al.
Publicado: (2015)

In-111 octreotide SPECT/CT in the early diagnosis of pulmonary sarcoidosis: A case report
por: Carbone, Roberto G., et al.
Publicado: (2021)

The utility of gallium-68 DOTATOC PET/CT in lymphangioleiomyomatosis
por: Gaffney, Brian, et al.
Publicado: (2021)

Prospective data-driven respiratory gating of [(68)Ga]Ga-DOTATOC PET/CT
por: Sigfridsson, Jonathan, et al.
Publicado: (2021)

Role of (68)Ga-DOTATOC PET/CT in the Evaluation of Primary Pulmonary Carcinoids
por: Jindal, Tarun, et al.
Publicado: (2010)

EVALUATION OF THE SPATIAL RESOLUTION IN MONTE CARLO-BASED SPECT/CT RECONSTRUCTION OF (111)IN-OCTREOTIDE IMAGES
por: Wikberg, Emma, et al.
Publicado: (2021)

(68)Ga-DOTATATE PET/CT versus (111)In-octreotide scintigraphy in patients with neuroendocrine tumors: a prospective study
por: Cavicchioli, Marcelo, et al.
Publicado: (2022)

Usefulness of (68)Ga-DOTATOC PET/CT to localize the culprit tumor inducing osteomalacia
por: Lee, Dong Yun, et al.
Publicado: (2021)

Thyroid metastasis from lung carcinoid detected by (68)Ga-DOTATOC PET/CT
por: Albano, Domenico, et al.
Publicado: (2021)

(68)Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditis
por: Boughdad, Sarah, et al.
Publicado: (2021)

[(68)Ga]DOTATOC PET/CT Radiomics to Predict the Response in GEP-NETs Undergoing [(177)Lu]DOTATOC PRRT: The “Theragnomics” Concept
por: Laudicella, Riccardo, et al.
Publicado: (2022)

Cost-Effectiveness Analysis of (68)Ga DOTA-TATE PET/CT, (111)In-Pentetreotide SPECT/CT and CT for Diagnostic Workup of Neuroendocrine Tumors
por: Froelich, Matthias Frank, et al.
Publicado: (2021)

111In-Octreoscan SPECT/CT hybrid imaging and 68Ga-DOTANOC PET/CT in neuroendocrine adenoma of the middle ear (NAME)
por: Pontico, Mariano, et al.
Publicado: (2020)

Diagnostic Efficiency of (68)Ga-DOTATATE PET/CT as Compared to (99m)Tc-Octreotide SPECT/CT and Conventional Morphologic Modalities in Neuroendocrine Tumors
por: Fallahi, Babak, et al.
Publicado: (2019)

Correction: (68)Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditis
Publicado: (2022)

Optic Nerve Sheath Meningiomas: Solving Diagnostic Challenges with (68)Ga-DOTATOC PET/CT
por: Horowitz, Tatiana, et al.
Publicado: (2023)

A novel statistical analysis method to improve the detection of hepatic foci of (111)In-octreotide in SPECT/CT imaging
por: Magnander, Tobias, et al.
Publicado: (2016)

Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by (68)Ga-DOTATOC PET/CT
por: Jahn, Ulrika, et al.
Publicado: (2021)

Diagnostic performance and impact on patient management of [(68)Ga]Ga-DOTA-TOC PET/CT in colorectal neuroendocrine tumors derived from hindgut
por: Delabie, Pierre, et al.
Publicado: (2022)

Relevance of Volumetric Parameters Applied to [(68)Ga]Ga-DOTATOC PET/CT in NET Patients Treated with PRRT
por: Urso, Luca, et al.
Publicado: (2023)

Staging of neuroendocrine tumours: comparison of [(68)Ga]DOTATOC multiphase PET/CT and whole-body MRI
por: Schraml, C., et al.
Publicado: (2013)

Primary phosphaturic mesenchymal tumour of the lumbar spine: utility of (68)Ga-DOTATOC PET/CT findings
por: Maehara, Junki, et al.
Publicado: (2016)

Gastrointestinal neuroendocrine tumor with discordant metastatic disease on 111In-pentetreotide SPECT/CT, 18F-DOPA PET/CT and 68Ga-HA-DOTATATE PET/CT
por: Resch, Katrin, et al.
Publicado: (2022)

Evaluation of the role of [(18)F]FDG-PET/CT and [(68)Ga]DOTATOC-PET/CT in differentiating typical and atypical pulmonary carcinoids
por: Jindal, Tarun, et al.
Publicado: (2011)

Splenosis Mimicking Relapse of a Neuroendocrine Tumor at Gallium-68-DOTATOC PET/CT
por: Treglia, Giorgio, et al.
Publicado: (2013)

The therapeutic efficacy of (177)Lu-DOTATATE/DOTATOC in advanced neuroendocrine tumors: A meta-analysis
por: Wang, Li-fan, et al.
Publicado: (2020)

Effective localization in tumor-induced osteomalacia using (68)Ga-DOTATOC-PET/CT, venous sampling and 3T-MRI
por: Kawai, Shintaro, et al.
Publicado: (2017)

THU036 (68)Ga-DOTATOC PET/CT In Localization Of ACTH-producing Pituitary Tumors In Patients With Cushing Disease
por: Kim, Kyungwon
Publicado: (2023)

Functional Imaging of Pheochromocytoma with (68)Ga-DOTATOC and (68)C-HED in a Genetically Defined Rat Model of Multiple Endocrine Neoplasia
por: Miederer, Matthias, et al.
Publicado: (2011)

(68)Ga-DOTATOC PET/CT Follow Up after Single or Hypofractionated Gamma Knife ICON Radiosurgery for Meningioma Patients
por: Barone, Fabio, et al.
Publicado: (2021)

Prospective study of dynamic whole-body 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors
por: Thuillier, Philippe, et al.
Publicado: (2021)

Diagnostic Impact of Dual-Time PET/CT with (68)Gallium-PSMA in Prostate Cancer and (68)Gallium-DOTATOC in Neuroendocrine Tumors
por: Librizzi, Damiano, et al.
Publicado: (2023)

Meningiomas: A Comparative Study of (68)Ga-DOTATOC, (68)Ga-DOTANOC and (68)Ga-DOTATATE for Molecular Imaging in Mice
por: Soto-Montenegro, María Luisa, et al.
Publicado: (2014)

Pindborg Tumor—An Uncommon Odontogenic Tumor Detected by 68Ga-DOTATOC
por: Herden, Anna, et al.
Publicado: (2022)

The Value of Somatostatin Receptor Imaging with In-111 Octreotide and/or Ga-68 DOTATATE in Localizing Ectopic ACTH Producing Tumors
por: Gözde Özkan, Zeynep, et al.
Publicado: (2013)

Detection of neuroendocrine tumours in the small intestines using contrast-enhanced multiphase Ga-68 DOTATOC PET/CT: the potential role of arterial hyperperfusion
por: Schreiter, Nils F., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4msdv0nbslitm44nsnrr3g6pdj